Profile data is unavailable for this security.
About the company
Anagenics Limited is an Australia-based health and beauty-tech company. The Company offers a range of clinically validated anti-ageing and wellness products developed in-house or sourced from premium international brands. The Company, through its wholly owned subsidiary Advangen Pty Ltd, develops, manufactures and markets anti-aging products globally, with its FGF5 inhibitor hair health and hair growth products sold worldwide. The flagship anti-aging hair care range, marketed as evolis, Advangen Jo-Ju and Lexilis brands, is sold in Japan, the United States of America and Australia. The Company’s subsidiary is BLC Cosmetics Pty Limited, which is the distributor of international and local skin care and wellbeing brands.
- Revenue in AUD (TTM)10.80m
- Net income in AUD-7.54m
- Incorporated2004
- Employees--
- LocationAnagenics LtdSuite 204, Level 2, 55 Clarence StreetSYDNEY 2000AustraliaAUS
- Phone+61 29221-6830
- Fax+61 29221-8535
- Websitehttps://anagenics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Skin Elements Ltd | 416.21k | -1.87m | 2.36m | -- | -- | -- | -- | 5.67 | -0.0033 | -0.0033 | 0.0007 | -0.0015 | 0.3412 | 0.9385 | 0.7643 | -- | -153.61 | -50.37 | -- | -57.71 | 86.95 | 69.51 | -450.21 | -725.46 | 0.4493 | -19.67 | -- | -- | 114.39 | -12.21 | 83.59 | -- | -- | -- |
Klinko Karya Imaji PT Tbk | 2.14m | 205.58k | 2.79m | 4.00 | 13.57 | 0.8408 | 7.10 | 1.30 | 1.62 | 1.62 | 16.87 | 26.17 | 0.5104 | 3.47 | 11.86 | 5,522,168,000.00 | 4.90 | -- | 5.08 | -- | 45.67 | -- | 9.60 | -- | 7.44 | 3.43 | 0.2018 | -- | 125.71 | -- | 143.88 | -- | -- | -- |
Anagenics Ltd | 10.80m | -7.54m | 3.69m | -- | -- | 1.36 | -- | 0.3416 | -0.0181 | -0.0188 | 0.0271 | 0.0059 | 1.23 | 3.33 | 12.74 | -- | -85.81 | -31.62 | -121.35 | -41.27 | 40.37 | 52.77 | -69.75 | -47.68 | 0.7609 | -61.85 | 0.2219 | -- | 18.54 | 7.67 | -332.64 | -- | 8.31 | -- |